Missing/wrong data?
Log in to edit
Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study).
scientific article published on 15 November 2017
Author/s
author: Joop A M J L Janssen, Sebastian J C M M Neggers, Ammar Muhammad, Patric J D Delhanty, Aart J van der Lely, Alof H G Dallenga
Work details
Publication date
February 1, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.